Your search returned 2 results.

Results
	1.	Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma. [electronic resource] by Ryan, Qin C Headlee, Donna Acharya, Milin Sparreboom, Alex Trepel, Jane B Ye, Joseph Figg, William D Hwang, Kyunghwa Chung, Eun Joo Murgo, Anthony Melillo, Giovanni Elsayed, Yusri Monga, Manish Kalnitskiy, Mikhail Zwiebel, James Sausville, Edward A Producer: 20050707 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment. [electronic resource] by Vidisheva, Aleksandra P Wang, James Spektor, Tanya M Bitran, Jacob D Lutzky, Jose Tabbara, Imad A Ye, Joseph Z Ailawadhi, Sikander Stampleman, Laura V Steis, Ronald G Moezi, Mehdi M Swift, Regina A Maluso, Tina M Udd, Kyle A Eshaghian, Shahrooz Nassir, Youram Berenson, James R Producer: 20181024 In: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search